Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Bone Biologics Corp. (BBLG) had Weighted-Average Shares Outstanding (Diluted) of 1.17M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.68M |
|
-- |
|
-- |
|
$0.73M |
|
$-0.73M |
|
$0.05M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.68M |
|
$-0.73M |
|
$-0.73M |
|
1.17M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.17M |
$0.97 |
|
$0.97 |
|
| Balance Sheet Financials | |
$5.80M |
|
-- |
|
-- |
|
$5.80M |
|
$0.42M |
|
-- |
|
-- |
|
$0.42M |
|
$5.38M |
|
$5.38M |
|
$5.38M |
|
1.79M |
|
| Cash Flow Statement Financials | |
$-2.69M |
|
-- |
|
$4.70M |
|
$3.33M |
|
$5.33M |
|
$2.01M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.73% |
|
-12.73% |
|
-11.81% |
|
-12.73% |
|
$3.00 |
|
$-2.29 |
|
$-2.29 |
|